Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
99.79
+1.39 (1.41%)
At close: Mar 9, 2026, 4:00 PM EDT
98.00
-1.79 (-1.79%)
After-hours: Mar 9, 2026, 6:59 PM EDT
Revolution Medicines Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -1,131 | -600.09 | -436.37 | -248.71 | -187.09 | |
| Depreciation & Amortization | 15.66 | 10.72 | 8.21 | 8.56 | 6.23 | |
| Other Amortization | 0.9 | 1.1 | 1.1 | 1.1 | 1.1 | |
| Loss (Gain) From Sale of Assets | 0.03 | 0.12 | 0.05 | 0.02 | 0.12 | |
| Loss (Gain) From Sale of Investments | -27.83 | -44.57 | -22.21 | -3.08 | 3.01 | |
| Stock-Based Compensation | 118.39 | 79.2 | 61.77 | 31.2 | 20.72 | |
| Other Operating Activities | 39.59 | -4.32 | 0.12 | - | - | |
| Change in Accounts Receivable | - | 1.25 | 3.42 | 1.26 | 0.46 | |
| Change in Accounts Payable | 9.54 | -6.47 | 32.47 | 7.29 | 2.24 | |
| Change in Unearned Revenue | - | - | -4.46 | -14.47 | -1.66 | |
| Change in Other Net Operating Assets | 77.29 | 6.38 | 9.23 | -7.14 | 7.68 | |
| Operating Cash Flow | -897.74 | -557.44 | -350.57 | -224.4 | -147.18 | |
| Capital Expenditures | -15.99 | -10.31 | -7.73 | -10.82 | -6.53 | |
| Investment in Securities | 134.05 | -544.09 | -334.87 | -13.3 | -135.59 | |
| Investing Cash Flow | 118.06 | -554.39 | -342.6 | -24.12 | -142.12 | |
| Issuance of Common Stock | 377.09 | 863.71 | 392.39 | 301.39 | 294.6 | |
| Repurchase of Common Stock | - | - | -4.03 | - | - | |
| Other Financing Activities | 244.44 | 95.71 | 840.83 | 0.04 | -0.42 | |
| Financing Cash Flow | 621.52 | 959.41 | 1,229 | 301.43 | 294.18 | |
| Net Cash Flow | -158.16 | -152.42 | 536.03 | 52.92 | 4.88 | |
| Free Cash Flow | -913.73 | -567.74 | -358.3 | -235.22 | -153.71 | |
| Free Cash Flow Margin | - | - | -3094.14% | -664.83% | -522.99% | |
| Free Cash Flow Per Share | -4.81 | -3.38 | -3.17 | -2.92 | -2.11 | |
| Levered Free Cash Flow | -523.28 | -347.69 | -159.75 | -132.84 | -84.69 | |
| Unlevered Free Cash Flow | -508.13 | -347.69 | -159.75 | -132.84 | -84.68 | |
| Change in Working Capital | 86.82 | 0.41 | 36.75 | -13.49 | 8.72 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.